IFNLR1 and prostate carcinoma: Analysis of publicly available datasets revealed that IL-28, and its cognate receptors IL28Rα and IL10Rβ were expressed in prostate carcinoma compared to prostate glandular epithelium (Supplementary Fig. 4).